Citations (16)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Karolina Merecz, Mikołaj Hirsa, Olga Biniszewska, Jakub Fichna & Aleksandra Tarasiuk. (2023) An overview of 5-HT3 receptor antagonists as a treatment option for irritable bowel syndrome with diarrhea. Expert Opinion on Pharmacotherapy 24:10, pages 1189-1198.
Read now
Read now
Konstantinos C Fragkos. (2017) Spotlight on eluxadoline for the treatment of patients with irritable bowel syndrome with diarrhea. Clinical and Experimental Gastroenterology 10, pages 229-240.
Read now
Read now
Articles from other publishers (14)
Mingming Li, Jiawei Zhu, Xuan Liu, Zhiying Dong, Jigui Tang, Cian Zhang, Jianpeng Jiao, Jiani Chen, Fenghao Yin, Shi Qiu, Feng Zhang, Shouhong Gao, Zhipeng Wang, Xia Tao, Xiaoqiang Yue, Lianna Sun & Wansheng Chen. (2022) Chaihu-Guizhi-Ganjiang Decoction is more efficacious in treating irritable bowel syndrome than Dicetel according to metabolomics analysis. Chinese Medicine 17:1.
Crossref
Crossref
Jinke Huang, Mengxiong Lu, Yijun Zheng, Jinxin Ma, Xiangxue Ma, Yitian Wang, Kunli Zhang, Fengyun Wang & Xudong Tang. (2021) Quality of Evidence Supporting the Role of Acupuncture for the Treatment of Irritable Bowel Syndrome. Pain Research and Management 2021, pages 1-10.
Crossref
Crossref
Michelle Bosman, Sigrid Elsenbruch, Maura Corsetti, Jan Tack, Magnus Simrén, Bjorn Winkens, Thimo Boumans, Ad Masclee & Daniel Keszthelyi. (2021) The placebo response rate in pharmacological trials in patients with irritable bowel syndrome: a systematic review and meta-analysis. The Lancet Gastroenterology & Hepatology 6:6, pages 459-473.
Crossref
Crossref
Hongmei Yang, Xin Liu, Wei Peng, Rong Chen & Yang Chen. (2021) Lipi Guben decoction in treating diarrheal irritable bowel syndrome. Medicine 100:3, pages e23887.
Crossref
Crossref
Fan-Long Bu, Mei Han, Chun-Li Lu, Xue-Han Liu, Wei-Guang Wang, Jing-Ling Lai, Xing-Hua Qiu, Bai-Xiang He, Han Zhang, Nicola Robinson, Yu-Tong Fei & Jian-Ping Liu. (2020) A systematic review of Tuina for irritable bowel syndrome: Recommendations for future trials. Complementary Therapies in Medicine 52, pages 102504.
Crossref
Crossref
Mark Hearn, Peter J Whorwell & Dipesh H Vasant. (2020) Stigma and irritable bowel syndrome: a taboo subject?. The Lancet Gastroenterology & Hepatology 5:6, pages 607-615.
Crossref
Crossref
Zsa Zsa R.M. Weerts, Ad A.M. Masclee, Ben J.M. Witteman, Cees H.M. Clemens, Bjorn Winkens, Jacobus R.B.J. Brouwers, Henderik W. Frijlink, Jean W.M. Muris, Niek J. De Wit, Brigitte A.B. Essers, Jan Tack, Johanna T.W. Snijkers, Andrea M.H. Bours, Annieke S. de Ruiter-van der Ploeg, Daisy M.A.E. Jonkers & Daniel Keszthelyi. (2020) Efficacy and Safety of Peppermint Oil in a Randomized, Double-Blind Trial of Patients With Irritable Bowel Syndrome. Gastroenterology 158:1, pages 123-136.
Crossref
Crossref
Yu. P. Uspensky, A. A. Gnutov, Yu. A. Fominykh & O. S. Mirzoev. (2019) Modern paradigm of functional diseases of gastrointestinal tract: focus on functional dyspepsia, sphincter of Oddi dysfunction and irritable bowel syndrome. Medical alphabet 3:20, pages 24-29.
Crossref
Crossref
Dipesh H. Vasant & Peter J. Whorwell. (2019) Gut‐focused hypnotherapy for Functional Gastrointestinal Disorders: Evidence‐base, practical aspects, and the Manchester Protocol. Neurogastroenterology & Motility 31:8.
Crossref
Crossref
Greger Lindberg. (2019) Pseudo-obstruction, enteric dysmotility and irritable bowel syndrome. Best Practice & Research Clinical Gastroenterology 40-41, pages 101635.
Crossref
Crossref
Esmeralda Juárez, Andy Ruiz, Omar Cortez, Eduardo Sada & Martha Torres. (2018) Antimicrobial and immunomodulatory activity induced by loperamide in mycobacterial infections. International Immunopharmacology 65, pages 29-36.
Crossref
Crossref
Maura Corsetti & Peter Whorwell. (2017) The global impact of IBS: time to think about IBS-specific models of care?. Therapeutic Advances in Gastroenterology 10:9, pages 727-736.
Crossref
Crossref
Longtu Chen, Sheikh J. Ilham & Bin Feng. (2017) Pharmacological Approach for Managing Pain in Irritable Bowel Syndrome: A Review Article. Anesthesiology and Pain Medicine 7:2.
Crossref
Crossref
Benjamin N. R. Cheyette & Sarah N. R. Cheyette. (2016) Acute exacerbation of irritable bowel syndrome prevented by prn oral triptan. Clinical Journal of Gastroenterology 9:6, pages 375-378.
Crossref
Crossref